Skip to main content

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS, EPS

Adobe

(ADBE) - Get Adobe Inc. Report

estimates, target lowered at Credit Suisse.ADBE estimates were cut through 2013. Company is spending more to try and boost future growth. Neutral rating and new $31 price target.

Adobe Systems numbers lowered at Oppenheimer through 2012. Few near term catalysts and limited margin expansion. Perform rating.

Advance Auto Parts

(AAP) - Get Advance Auto Parts, Inc. Report

downgraded at Credit Suisse from Outperform to Neutral. $70 price target. Company is investing more into future growth.

Advance Auto Parts estimates, target increased at UBS.Shares of AAP now seen reaching $72. Sharp EPS beat moves estimates higher. Neutral rating.

Ashland

(ASH) - Get Ashland Global Holdings, Inc. Report

upgraded at JP Morgan from Neutral to Overweight. $62 price target. ISP acquisition should add to earnings

Bed Bath & Beyond

TheStreet Recommends

(BBBY) - Get Bed Bath & Beyond Inc. Report

estimates, target raised at Oppenheimer. Shares of BBBY now seen reaching $74. Estimates also increased given underlying sales stability. Outperform rating.

Bill Barrett

(BBG)

upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Higher oil prices should help drive cash flow growth.

CarMax

(KMX) - Get CarMax, Inc. Report

rated new Buy at Stifel Nicolaus. $36 price target. Company is a market leader that enjoys high barriers to entry.

Catalyst Health Solutions

( CHSI) numbers cut at Citigroup.Shares of CHSI now seen reaching $63. Estimates also lowered on plans to increase its PBM offering. Buy rating.

Cisco Systems

(CSCO) - Get Cisco Systems, Inc. Report

upgraded at Citigroup from Neutral to Buy. $22 price target. Solid execution, accelerating order growth, and balanced strength across geographies.

Cisco Systems numbers boosted at Credit Suisse. Shares of CSCO now seen reaching $26, according to Credit Suisse. Estimates also upped, to match the company's new guidance. Outperform rating.

Cisco Systems upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $22 price target. Company is carrying a lot of momentum into 2012.

Cisco Systems numbers raised at Oppenheimer. CSCO estimates were raised through 2012, Oppenheimer said. The company produced solid execution and a renewed focus in the October quarter. Outperform rating.

Cisco Systems estimates raised at UBS through 2013, UBS said. Healthy Jan-Q visibility and demand, outlook appropriately conservative. Maintain $20 price target and Buy rating.

Computer Sciences Corporation

(CSC)

estimates, target lowered at Citigroup.Shares of CSC now seen reaching $30, according to Citigroup. Estimates also lowered as company lowers top line guidance on continued public sector weakness. Neutral rating.

Computer Sciences downgraded to sell at TheStreet Ratings.

Computer Sciences numbers reduced at Goldman. Shares of CSC now seen reaching $25, according to Goldman Sachs. Estimates also cut, as the company will likely see lower margins in the coming quarters. Sell rating.

Concho Resources

(CXO) - Get Concho Resources Inc. Report

downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Valuation call.

Eastman Chemical

(EMN) - Get Eastman Chemical Company Report

rated new Buy at Ticonderoga. $56 price target. Company can continue to generate solid cash flow and return it to investors.

General Motors

(GM) - Get General Motors Company (GM) Report

estimates, target lowered at Citigroup.Shares of GM now seen reaching $37. Estimates also lowered on anticipated macro pressure in Europe and S.A. Buy rating.

General Motors estimates cut at Morgan Stanley through 2013. Company is facing higher engineering and marketing costs. Overweight rating and $45 price target.

General Motors estimates lowered at UBS through 2012. Low quality beat and soft 4Q view. Maintain $28 price target and Buy rating.

HCA Inc

(HCA) - Get HCA Healthcare Inc (HCA) Report

numbers lowered at Oppenheimer. HCA estimates lowered through this year, Oppenheimer said. As a result of the SEC mandated accounting change. Outperform rating.

Kellogg

(K) - Get Kellogg Company (K) Report

downgraded at Deutsche from Buy to Hold. $50 price target. Company is investing more into future growth.

Macy's

(M) - Get Macy's Inc Report

estimates, target raised at Goldman. Shares of M now seen reaching $32. Estimates also increased, as the company is buying back more stock. Neutral rating.

MakeMyTrip

(MMYT) - Get MakeMyTrip Ltd. Report

target raised at Oppenheimer. Shares of MMYT now seen reaching $34. The company bucked September quarter seasonality reporting better than expected results. Outperform rating.

Manitowoc

(MTW) - Get Manitowoc Company, Inc. Report

numbers increased at UBS. Shares of MTW now seen reaching $12. Estimates also increased on improving capex outlook. Neutral rating.

Murphy Oil Corporation

(MUR) - Get Murphy Oil Corporation Report

numbers lowered at Oppenheimer. MUR estimates lowered through 2012. The company has turned the corner on production decline. Outperform rating.

PG&E

(PCG) - Get PG&E Corporation Report

downgraded at Credit Suisse from Outperform to Neutral. $44 price target. California resolution remains way off in the future.

Ralph Lauren

(RL) - Get Ralph Lauren Corporation Class A Report

numbers increased at Goldman. RL estimates were raised through 2014. Company is buying back more stock. Neutral rating and new $154 price target.

Rosetta Resources

(ROSE) - Get Rosehill Resources Inc. Class A Report

numbers upped at Credit Suisse.ROSE estimates were boosted through 2013. Company increased its guidance. Outperform rating and new $67 price target.

Sandridge Energy

(SD) - Get SandRidge Energy, Inc. Report

downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Valuation call.

Spreadtrum

(SPRD)

estimates, target raised at Jefferies.Shares of SPRD now seen reaching $36. Estimates also increased, as new products should continue to drive growth. Buy rating.

Terex

(TEX) - Get Terex Corporation Report

estimates, target increased at UBS.Shares of TEX now seen reaching $16. Estimates also raised on improving capex outlook. Neutral rating.

VeriFone

(PAY)

upgraded to buy at TheStreet Ratings.

Vertex Pharmaceuticals

(VRTX) - Get Vertex Pharmaceuticals Incorporated Report

upgraded at Morgan Stanley from Underweight to Equal-weight. Valuation call, based on a $32 price target.

Wendy's

(WEN) - Get Wendy's Company Report

downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $5.75 price target. Potential turnaround will continue to take more time and money.

Wendy's estimates raised at UBS through 2012, UBS said. Belief in company's ability to drive sales and profitability in the near term through new menu offerings. Maintain $6.30 price target and Buy rating.

Williams-Sonoma

(WSM) - Get Williams-Sonoma, Inc. Report

numbers lowered at Oppenheimer. WSM estimates lowered though 2012, according to Oppenheimer. The industry is facing ongoing economic uncertainty in the U.S. and abroad. Outperform rating.

>To submit a news tip, email:

tips@thestreet.com

.

RELATED STORIES:

>>U.S. Debt Crisis: What's the End Game

>>Kass: 6 Reasons to Buy American

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

David Peltier is a research associate at TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks. He also doesn't invest in hedge funds or other private investment partnerships. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Peltier appreciates your feedback;

click here

to send him an email.